Sorrento Therapeutics Inc
Sector: Manufacturing
Industry: Pharmaceutical Products
0.00
N/A
(N/A%)
Volume:
37,523
52 week range:
N/A - N/A
Market Cap:
18.192M
Company Description:
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, viral and neurodegenerative diseases. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment.